Testing a new drug in healthy adults
Part of Pain clinical trials.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be in overall good health with no serious medical conditions
- Weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female
- Have a healthy weight range (BMI between 18–32)
- Not have a personal or family history of certain heart rhythm problems
- Be willing to stop all medications and supplements for at least 2 weeks before the study
- Not smoke more than 5 cigarettes per day and be able to quit during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This first-in-human trial tests a new medicine called GRT7041 in healthy people to see how safe it is and how it works in the body. It helps doctors understand the right dose and any side effects before testing in patients.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medicine called KR25102 to see if it is safe and how the body handles it. It may help develop a treatment for pain.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.